kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance Mechanisms of Resistance to KRAS
Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt Tanaka 2025 Cancer Science Wiley Online Library Impact of KRAS mutation on the tumor microenvironment in colorectal cancer KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports KRAS OriGene Technologies Inc. BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




